{"id":"https://openalex.org/W7203671977","doi":"https://doi.org/10.1248/bpbreports.9.4_100","title":"Differential Recovery of Anti-Influenza Agent Utilization in Japan After the COVID-19 Pandemic: A Nationwide Analysis Using NDB Open Data (2019\u20132024)","display_name":"Differential Recovery of Anti-Influenza Agent Utilization in Japan After the COVID-19 Pandemic: A Nationwide Analysis Using NDB Open Data (2019\u20132024)","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7203671977","doi":"https://doi.org/10.1248/bpbreports.9.4_100"},"language":"en","primary_location":{"id":"doi:10.1248/bpbreports.9.4_100","doi":"https://doi.org/10.1248/bpbreports.9.4_100","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpbreports.9.4_100","pdf_url":"https://www.jstage.jst.go.jp/article/bpbreports/9/4/9_100/_pdf","source":{"id":"https://openalex.org/S4210207390","display_name":"BPB Reports","issn_l":"2434-432X","issn":["2434-432X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BPB Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/bpbreports/9/4/9_100/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027676081","display_name":"Atsushi Ishimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Atsushi Ishimura","raw_affiliation_strings":["Laboratory of Clinical Pharmacy Assessment, Hoshi University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Pharmacy Assessment, Hoshi University","institution_ids":["https://openalex.org/I36296616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5027676081"],"corresponding_institution_ids":["https://openalex.org/I36296616"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.55096569,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"4","first_page":"100","last_page":"102"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-influenza-agents","display_name":"anti-influenza agents","score":0.9440000057220459},{"id":"https://openalex.org/keywords/seasonal-influenza","display_name":"seasonal influenza","score":0.6869999766349792},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9629999995231628},{"id":"https://openalex.org/keywords/medication-use","display_name":"medication use","score":0.6800000071525574},{"id":"https://openalex.org/keywords/oseltamivir","display_name":"oseltamivir","score":0.871999979019165},{"id":"https://openalex.org/keywords/baloxavir","display_name":"baloxavir","score":0.9879999756813049},{"id":"https://openalex.org/keywords/zanamivir","display_name":"zanamivir","score":1.0},{"id":"https://openalex.org/keywords/laninamivir","display_name":"laninamivir","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.7300000190734863},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.6129999756813049},{"id":"https://openalex.org/keywords/post-pandemic-recovery","display_name":"post-pandemic recovery","score":0.8669999837875366},{"id":"https://openalex.org/keywords/japan","display_name":"Japan","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.515500009059906},{"id":"https://openalex.org/C93226319","wikidata":"https://www.wikidata.org/wiki/Q193137","display_name":"Differential (mechanical device)","level":2,"score":0.3379000127315521},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.28450000286102295},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2508000135421753},{"id":"https://openalex.org/C2986587452","wikidata":"https://www.wikidata.org/wiki/Q938438","display_name":"Statistical analysis","level":2,"score":0.23680000007152557},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.22789999842643738},{"id":"https://openalex.org/C133462117","wikidata":"https://www.wikidata.org/wiki/Q4929239","display_name":"Data collection","level":2,"score":0.20280000567436218},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2004999965429306},{"id":"https://openalex.org/C2778348673","wikidata":"https://www.wikidata.org/wiki/Q739302","display_name":"Production (economics)","level":2,"score":0.19910000264644623},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.19830000400543213}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1248/bpbreports.9.4_100","doi":"https://doi.org/10.1248/bpbreports.9.4_100","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpbreports.9.4_100","pdf_url":"https://www.jstage.jst.go.jp/article/bpbreports/9/4/9_100/_pdf","source":{"id":"https://openalex.org/S4210207390","display_name":"BPB Reports","issn_l":"2434-432X","issn":["2434-432X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BPB Reports","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1248/bpbreports.9.4_100","doi":"https://doi.org/10.1248/bpbreports.9.4_100","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpbreports.9.4_100","pdf_url":"https://www.jstage.jst.go.jp/article/bpbreports/9/4/9_100/_pdf","source":{"id":"https://openalex.org/S4210207390","display_name":"BPB Reports","issn_l":"2434-432X","issn":["2434-432X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BPB Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7203671977.pdf","grobid_xml":"https://content.openalex.org/works/W7203671977.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387331527","https://openalex.org/W7204989960","https://openalex.org/W3070930823","https://openalex.org/W1543562000","https://openalex.org/W2989090529","https://openalex.org/W7139223062","https://openalex.org/W7165677184","https://openalex.org/W4413048809","https://openalex.org/W1928134339","https://openalex.org/W4220667746"],"abstract_inverted_index":{"The":[0,188],"coronavirus":[1],"disease":[2],"2019":[3],"(COVID-19)":[4],"pandemic":[5],"substantially":[6,124,170],"altered":[7],"the":[8,16,26,36,44,50,60,102,120,129,136,159,185,210],"epidemiology":[9],"of":[10,18,28,39,54,63,108,131,178,212],"seasonal":[11],"influenza":[12,22,132,213],"and":[13,67,84,117,145],"markedly":[14,114],"reduced":[15],"utilization":[17,37,168,176,198],"anti-influenza":[19,40,55,111,179],"agents.":[20,173],"Although":[21],"activity":[23],"resumed":[24],"following":[25,128,184],"relaxation":[27],"public":[29],"health":[30],"interventions,":[31],"it":[32],"remains":[33],"unclear":[34],"whether":[35],"patterns":[38,122,177,199],"agents":[41,56,112,127,180,194],"returned":[42],"to":[43,157,209],"pre-pandemic":[45,160],"state":[46],"or":[47],"changed":[48,183],"after":[49],"pandemic.":[51,187],"Prescription":[52],"volumes":[53,96],"were":[57,86,97],"extracted":[58],"from":[59],"National":[61],"Database":[62],"Health":[64,69],"Insurance":[65],"Claims":[66],"Specific":[68],"Checkups":[70],"Open":[71,74],"Data":[72],"(NDB":[73],"Data)":[75],"for":[76,141,147],"fiscal":[77],"years":[78],"(FY)":[79],"2019\u20132024.":[80],"Oseltamivir,":[81],"baloxavir,":[82],"zanamivir,":[83],"laninamivir":[85],"evaluated.":[87],"To":[88],"compare":[89],"temporal":[90],"changes":[91],"among":[92,125,171,192],"antiviral":[93,126,172,193],"agents,":[94],"prescription":[95,137],"normalized":[98],"using":[99],"FY2019":[100],"as":[101],"reference":[103],"(index":[104],"=":[105],"100).":[106],"Utilization":[107],"all":[109],"evaluated":[110],"declined":[113],"during":[115],"FY2020":[116],"FY2021.":[118],"However,":[119],"recovery":[121,190],"differed":[123,169],"resumption":[130],"activity.":[133,214],"In":[134,174],"FY2024,":[135],"index":[138],"reached":[139],"297.0":[140],"baloxavir":[142],"20-mg":[143],"tablets":[144],"191.6":[146],"oseltamivir":[148],"capsules/tablets,":[149],"whereas":[150],"zanamivir":[151],"remained":[152],"at":[153],"57.2.":[154],"Laninamivir":[155],"recovered":[156],"nearly":[158],"level.":[161],"These":[162],"findings":[163],"indicate":[164],"that":[165,196],"post-pandemic":[166,197],"drug":[167],"conclusion,":[175],"in":[181,207],"Japan":[182],"COVID-19":[186],"heterogeneous":[189],"observed":[191],"suggests":[195],"may":[200],"have":[201],"been":[202],"influenced":[203],"by":[204],"drug-specific":[205],"characteristics":[206],"addition":[208],"resurgence":[211]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2026-08-19T00:00:00"}